The transcatheter valve technology pipeline has started as simple balloon valvuloplasty for
the treatment of stenotic heart valves and evolved since the year 2000 to either repair or …

Background Transcatheter valve-in-valve (VIV) implantation in failing bioprosthesis is an
emerging field in cardiology. Aim To report on a French multicentre experience and a …

Transcatheter aortic valve implantation has established itself as an alternative treatment for
patients with valvular disease. In the current context of increasing bioprosthetic valve …

Background—Severe tricuspid valve (TV) dysfunction may lead to surgical TV replacement
with a biological valve prosthesis in patients with congenital heart disease. To expand the …

Transcatheter therapies in structural heart disease have evolved tremendously over the past
15 years. Since the introduction of the first balloon-expandable valves for stenotic lesions …

TAVI (transcatheter aortic valve implantation) is a less invasive treatment of the stenotic
aortic valve while avoiding midline sternotomy and cardiopulmonary bypass. A crimped …

Secondary tricuspid regurgitation is the most frequent type of tricuspid insufficiency in
western countries. Its surgical treatment is still an object of debate both in terms of timing and …

Introduction Transcatheter aortic valve implantation (TAVI) has become an alternative to
open surgery in those deemed high risk. The purpose of this study was to evaluate the …

A novel approach to reoperative tricuspid valve replacement using the transcatheter valve‐
in‐valve concept is studied. Three consecutive transapica transcatheter tricuspid Sapien …

Minimally invasive transcatheter technologies have demonstrated substantial promise for
the diagnosis and the treatment of cardiovascular diseases. For example, transcatheter …